Your browser doesn't support javascript.
Whole-genome sequence analysis reveals the circulation of multiple SARS-CoV-2 variants of concern in Nairobi and neighboring counties, Kenya between March and July 2021.
Khamadi, Samoel Ashimosi; Opanda, Silvanos; Symekher, Samwel Lifumo; Limbaso, Samson Konongoi; Langat, Solomon; Cirindi, Josyline Kaburi; Mwangi, Milkah; Mwikwabe, Nicholas; Okeyo, Seth; Koskei, Edith; Mutisya, James; Owaka, Samwel; Nyunja, Albert; Koka, Hellen; Wadegu, Meshack; Chitechi, Esther; Achilla, Rachel; Majanja, Janet Masitsa; Kanyara, Lucy; Amukoye, Evans; Bulimo, Wallace.
  • Khamadi SA; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Opanda S; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Symekher SL; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Limbaso SK; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Langat S; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Cirindi JK; Centre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Mwangi M; Centre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Mwikwabe N; Centre for Traditional Medicine and Drug Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Okeyo S; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Koskei E; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Mutisya J; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Owaka S; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Nyunja A; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Koka H; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Wadegu M; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Chitechi E; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Achilla R; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Majanja JM; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Kanyara L; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
  • Amukoye E; Centre for Respiratory Diseases Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Bulimo W; Centre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya. Wbulimo@kemri.org.
Virol J ; 19(1): 178, 2022 11 08.
Article in English | MEDLINE | ID: covidwho-2108842
ABSTRACT
The emergence and rapid spread of SARS-CoV-2 variants of concern (VOC) have been linked to new waves of COVID-19 epidemics occurring in different regions of the world. The VOC have acquired adaptive mutations that have enhanced virus transmissibility, increased virulence, and reduced response to neutralizing antibodies. Kenya has experienced six waves of COVID-19 epidemics. In this study, we analyzed 64 genome sequences of SARS-CoV-2 strains that circulated in Nairobi and neighboring counties, Kenya between March 2021 and July 2021. Viral RNA was extracted from RT-PCR confirmed COVID-19 cases, followed by sequencing using the ARTIC network protocol and Oxford Nanopore Technologies. Analysis of the sequence data was performed using different bioinformatics methods. Our analyses revealed that during the study period, three SARS-CoV-2 variants of concern (VOC) circulated in Nairobi and nearby counties in Kenya. The Alpha (B.1.1.7) lineage predominated (62.7%), followed by Delta (B.1.617.2, 35.8%) and Beta (B.1.351, 1.5%). Notably, the Alpha (B.1.1.7) VOC were most frequent from March 2021 to May 2021, while the Delta (B.1.617.2) dominated beginning June 2021 through July 2021. Sequence comparisons revealed that all the Kenyan viruses were genetically similar to those that circulated in other regions. Although the majority of Kenyan viruses clustered together in their respective phylogenetic lineages/clades, a significant number were interspersed among foreign strains. Between March and July 2021, our study's findings indicate the prevalence of multiple lineages of SAR-CoV-2 VOC in Nairobi and nearby counties in Kenya. The data suggest that the recent increase in SARS-CoV-2 infection, particularly in Nairobi and Kenya as a whole, is attributable to the introduction and community transmission of SARS-CoV-2 VOC among the populace. In conclusion, the findings provide a snapshot of the SARS-CoV-2 variants that circulated in Kenya during the study period.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Virol J Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: S12985-022-01895-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Virol J Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: S12985-022-01895-y